Results 21 to 30 of 158 matches
Category 6 - PATHOLOGY SERVICES
73308 - Additional Information
Characterisation of the genotype of a patient for Factor V Leiden gene mutation, or detection of the other relevant mutations in the investigation of proven venous thrombosis or pulmonary embolism - 1 or more tests
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73309 - Additional Information
A test described in item 73308, if rendered by a receiving APP - 1 or more tests
(Item is subject to rule 18)
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73310 - Additional Information
Measurable residual disease (MRD) testing by next-generation sequencing, performed on bone marrow (or a peripheral blood sample if bone marrow cannot be collected) from a patient diagnosed with acute lymphoblastic leukaemia, for the purpose of determining baseline MRD, or facilitating the determination of MRD following combination chemotherapy or after salvage therapy, requested by a specialist or consultant physician practising as a haematologist or oncologist
Fee: $1,550.00 Benefit: 75% = $1,162.50 85% = $1,451.30
(See para PN.0.35 of explanatory notes to this Category)
Category 6 - PATHOLOGY SERVICES
73311 - Additional Information
Characterisation of the genotype of a person who is a first degree relative of a person who has proven to have 1 or more abnormal genotypes under item 73308 - 1 or more tests
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73312 - Additional Information
A test described in item 73311, if rendered by a receiving APP - 1 or more tests
(Item is subject to rule 18)
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73314 - Additional Information
Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of:
(a) acute myeloid leukaemia; or
(b) acute promyelocytic leukaemia; or
(c) acute lymphoid leukaemia; or
(d) chronic myeloid leukaemia;
Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35
Category 6 - PATHOLOGY SERVICES
73315 - Additional Information
A test described in item 73314, if rendered by a receiving APP - 1 or more tests
(Item is subject to rule 18)
Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35
Category 6 - PATHOLOGY SERVICES
73317 - Additional Information
Detection of the C282Y genetic mutation of the HFE gene and, if performed, detection of other mutations for haemochromatosis where:
(a) the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or
(b) the patient has a first degree relative with haemochromatosis; or
(c) the patient has a first degree relative with homozygosity for the C282Y genetic mutation, or with compound heterozygosity for recognised genetic mutations for haemochromatosis
(Item is subject to rule 20)
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73318 - Additional Information
A test described in item 73317, if rendered by a receiving APP - 1 or more tests
(Item is subject to rule 18 and 20)
Fee: $36.45 Benefit: 75% = $27.35 85% = $31.00
Category 6 - PATHOLOGY SERVICES
73320 - Additional Information
Detection of HLA-B27 by nucleic acid amplification
includes a service described in 71147 unless the service in item 73320 is rendered as a pathologist determinable service.
(Item is subject to rule 27)
Fee: $40.55 Benefit: 75% = $30.45 85% = $34.50
Results 21 to 30 of 158 matches
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change